APA (7th ed.) Citation

S, S., G, P., C, B., I, M., S, P., E, B., . . . A, F. (2025). Optimization of Lipoplexes Functionalized with a Sialic Acid Mimetic (F9-PEG) to Target the C1858T PTPN22 Variant for Preclinical Assessment of a Novel Immunotherapy in Endocrine Autoimmunity. Pharmaceutics, 17(6), . https://doi.org/10.3390/pharmaceutics17060710

Chicago Style (17th ed.) Citation

S, Sennato, et al. "Optimization of Lipoplexes Functionalized with a Sialic Acid Mimetic (F9-PEG) to Target the C1858T PTPN22 Variant for Preclinical Assessment of a Novel Immunotherapy in Endocrine Autoimmunity." Pharmaceutics 17, no. 6 (2025). https://doi.org/10.3390/pharmaceutics17060710.

MLA (9th ed.) Citation

S, Sennato, et al. "Optimization of Lipoplexes Functionalized with a Sialic Acid Mimetic (F9-PEG) to Target the C1858T PTPN22 Variant for Preclinical Assessment of a Novel Immunotherapy in Endocrine Autoimmunity." Pharmaceutics, vol. 17, no. 6, 2025, https://doi.org/10.3390/pharmaceutics17060710.